(PRESS RELEASE) AIRPORT CITY, ISRAEL – NovaSight Ltd., a global leader in digital vision care solutions, announces that its innovative, home-based digital therapy for amblyopia (lazy eye) is now covered by Anthem Blue Cross and Blue Shield (Elevance Health, Inc.) insurance plans.
This marks a pivotal milestone in the transformation of pediatric vision care, significantly expanding access to effective amblyopia treatment for children across the United States.
This new development follows the inclusion of CureSight’s amblyopia therapy under Anthem’s updated medical policy (MED.00145 – Digital Therapy Devices for Treatment of Amblyopia), which now recognizes home-based digital treatments for amblyopia as medically necessary for children aged 4 to 9 years. Anthem, one of the largest health benefits companies in the United States, now enables millions of families to access NovaSight’s FDA-cleared, clinically validated solution with the support of their health insurance.
This policy includes three dedicated CPT codes for CureSight: two technical components for the supply, installation and remote treatment management, and one professional component for physician services related to remote patient and treatment monitoring.
“Our mission has always been to reshape the future of vision care using cutting-edge technology,” said Ran Yam, CEO and co-founder of NovaSight. “This insurance coverage decision reflects the growing recognition of the clinical value of our eye-tracking-based therapy and represents a major win for both providers and families.”
The support and advocacy from the American Academy of Ophthalmology (AAO) and the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) played a critical role in achieving this milestone. Their leadership has been instrumental in shaping a path forward for broader adoption of digital therapies in pediatric ophthalmology.
Advertisement
“This coverage decision is a game-changer for pediatric eye care,” said Dr. John M. DeVaro, pediatric ophthalmologist at Children’s Eye Institute of Savannah. “CureSight offers a more engaging and effective alternative to patching, and with insurance coverage now in place, we can finally provide this advanced treatment to more children who need it—regardless of their financial background. It’s a major step forward for both patients and providers. Healthcare providers and families should be encouraged to explore this newly covered treatment option and join the movement towards effective and more accessible eye care for children.”
